Over the past decade, organoids are being increasingly used in a range of applications, including disease modeling, pathogenesis, drug screening, and regenerative medicine, and the trend is set to continue during the forecast period. Organoid technologies have witnessed considerable developments in recent years, and continue to pave the way for the development of in vitro physiologic systems that model the origin tissues with high degree of accuracy compared to conventional approaches. The increasing focus on research and development activities is expected to play a key role in the development of the global organoids market during the assessment period.
The capability of 3D-organoid cultures to mimic organ functionality to some degree is one of the key factors likely to establish organoids as an ideal model for applications such as stem cell research to precision medicine. Furthermore, the increasing adoption of the organoid technology for use in a range of applications, including genetic mutation, gene assessment, and tumor modelling is expected to accelerate the overall development of the global organoids market during the assessment period. The assessment of different diseases by leveraging the organoid technology is anticipated to remain one of the most prominent applications of organoids in the upcoming years.
At the back of these factors coupled with the consistent rise in the investment for research and development, the global orgnoids market is expected to cross the market value of US$ 12.8 Bn by the end of 2030.
Request a sample to get extensive insights into the Organoids Market
The consistent progress in the organoid technology has gradually paved the way for ‘tumouroids’ and patient-centric 3D cultures of cells that are isolated from tumor biopsies. Over the past few decades, tumouroid lines have been established from a plethora of cancer types such as liver, breast, prostate, brain, bladder, and more from metastasis as well as primary tumors. Due to consistent advancements, in the current scenario, tumouroid lines are increasingly being passed in vitro, which opens up new avenues for a range of downstream applications. Moreover, 3D-based cultures offer additional advantages over the conventional 2D cancer-derived cell lines. Moreover, research and development activities have indicated that tumouroid culturing is highly efficient in enabling the collection of various cancer subtypes from a large pool of patients. As organoids can be easily derived and expanded from single cancer cells, the adoption of organoids to mimic intratumour diversification in culture is on the rise– a factor that is projected to propel the global organoids market during the assessment period.
To understand how our report can bring difference to your business strategy, Ask for a brochure
Research and development activities are set to play a key role in the overall development of the global organoids market during the assessment period. In addition, increasing collaborations between researchers and medical experts are anticipated to accelerate the development of complex organoids. For instance, two recent discoveries are expected to boost the overall prospects of next-generation organoid development. The new research collaboration between a team of scientists from the Cincinnati Children’s and Japan was announced in August 2020. As per the research team, discoveries from the new research collaboration are likely to be one of the most critical aspects for the development of a new wave of complex organoids. Although the organoid technology has progressed at a consistent pace over the past few years, the application of the same continues to remain sluggish in the current scenario. However, increasing focus on the commercialization of organoids and consistent progress in genome editing techniques are expected to bolster the growth of the global organoids market during the assessment period.
The advent of the novel COVID-19 pandemic is anticipated to open up new opportunities for the players involved in the current organoids market landscape. While researchers continue to assess the biology of the novel coronavirus, human and animal organoids are gradually anticipated to prove their value as an experimental virology platform. Furthermore, several researchers from various regions of the world have turned toward organoid technologies to assess the tissue tropism of the novel SARS-COV-2 virus.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Organoids Market
Analysts’ Viewpoint
The global organoids market is projected to expand at a high CAGR during the assessment period. Increasing prevalence of several diseases, outbreak of the novel COVID-19 pandemic, and rising adoption of organoids for disease modelling, gene mutation, and tumor modelling, advancements in organoid technology, and research and development activities are some of the key factors that are likely to drive the global organoids market during the assessment period. Furthermore, the increasing adoption of organoids as an ideal tool for respiratory infections and diseases will bolster the growth of the global organoids market during the assessment period.
Organoids Market – Segmentation
|
Type |
|
|
Application |
|
|
Source |
|
|
Region |
|
Organoids market is expected to cross the market value of US$ 12.8 Bn by the end of 2030
Organoids market is projected to expand at a high CAGR from 2020 to 2030
Organoids market is driven by rising adoption of organoids for disease modelling, gene mutation, and tumor modelling, advancements in organoid technology, and research and development activities
The developmental biology segment accounted for a major share of the organoids market, owing to its consideration as primary investigative research tool of the human developmental biology
Key players operating in the global organoids market include STEMCELL Technologies Inc., Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Inc., Organoid Therapeutics, PeproTech, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Organoids Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Organoids Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario by Region/globally
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Technological Advancements
5.4. COVID-19 Pandemic Impact on Global Organoids Market
6. Global Organoids Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Organoids Market Value Forecast, by Type,2018–2030
6.3.1. Stomach
6.3.2. Intestine
6.3.3. Liver
6.3.4. Pancreas
6.3.5. Lung
6.3.6. Brain
6.3.7. Kidney
6.3.8. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Organoids Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Organoids Market Value Forecast, by Application, 2018–2030
7.3.1. Developmental Biology
7.3.2. Disease Pathology of Infectious Disease
7.3.3. Regenerative Medicine
7.3.4. Drug Toxicity & Efficacy Testing
7.3.5. Drug Discovery & Personalized Medicine
7.3.6. Others
7.4. Global Organoids Market Attractiveness Analysis, by Application
8. Global Organoids Market Analysis and Forecast, by Source
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Organoids Market Value Forecast, by Source, 2018–2030
8.3.1. Pluripotent Stem Cells (hIPSCs)
8.3.2. Organ-speci?c Adult Stem Cells (ASCs)
8.4. Global Organoids Market Attractiveness Analysis, by Source
9. Global Organoids Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Organoids Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Organoids Market Attractiveness Analysis, by Region
10. North America Organoids Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Organoids Market Value Forecast, by Type,2018–2030
10.2.1. Stomach
10.2.2. Intestine
10.2.3. Liver
10.2.4. Pancreas
10.2.5. Lung
10.2.6. Brain
10.2.7. Kidney
10.2.8. Others
10.3. North America Organoids Market Value Forecast, by Application, 2018–2030
10.3.1. Developmental Biology
10.3.2. Disease Pathology of Infectious Disease
10.3.3. Regenerative Medicine
10.3.4. Drug Toxicity & Efficacy Testing
10.3.5. Drug Discovery & Personalized Medicine
10.3.6. Others
10.4. North America Organoids Market Value Forecast, by Source, 2018–2030
10.4.1. Pluripotent Stem Cells (hIPSCs)
10.4.2. Organ-speci?c Adult Stem Cells (ASCs)
10.5. North America Organoids Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Organoids Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By Source
10.6.4. By Country
11. Europe Organoids Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Organoids Market Value Forecast, by Type,2018–2030
11.2.1. Stomach
11.2.2. Intestine
11.2.3. Liver
11.2.4. Pancreas
11.2.5. Lung
11.2.6. Brain
11.2.7. Kidney
11.2.8. Others
11.3. Europe Organoids Market Value Forecast, by Application, 2018–2030
11.3.1. Developmental Biology
11.3.2. Disease Pathology of Infectious Disease
11.3.3. Regenerative Medicine
11.3.4. Drug Toxicity & Efficacy Testing
11.3.5. Drug Discovery & Personalized Medicine
11.3.6. Others
11.4. Europe Organoids Market Value Forecast, by Source, 2018–2030
11.4.1. Pluripotent Stem Cells (hIPSCs)
11.4.2. Organ-speci?c Adult Stem Cells (ASCs)
11.5. Europe Organoids Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Organoids Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By Source
11.6.4. By Country/Sub-region
12. Asia Pacific Organoids Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Organoids Market Value Forecast, by Type,2018–2030
12.2.1. Stomach
12.2.2. Intestine
12.2.3. Liver
12.2.4. Pancreas
12.2.5. Lung
12.2.6. Brain
12.2.7. Kidney
12.2.8. Others
12.3. Asia Pacific Organoids Market Value Forecast, by Application, 2018–2030
12.3.1. Developmental Biology
12.3.2. Disease Pathology of Infectious Disease
12.3.3. Regenerative Medicine
12.3.4. Drug Toxicity & Efficacy Testing
12.3.5. Drug Discovery & Personalized Medicine
12.3.6. Others
12.4. Asia Pacific Organoids Market Value Forecast, by Source, 2018–2030
12.4.1. Pluripotent Stem Cells (hIPSCs)
12.4.2. Organ-speci?c Adult Stem Cells (ASCs)
12.5. Asia Pacific Organoids Market Value Forecast, by Country/Sub-region, 2018–2030
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Organoids Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By Source
12.6.4. By Country/Sub-region
13. Latin America Organoids Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Organoids Market Value Forecast, by Type,2018–2030
13.2.1. Stomach
13.2.2. Intestine
13.2.3. Liver
13.2.4. Pancreas
13.2.5. Lung
13.2.6. Brain
13.2.7. Kidney
13.2.8. Others
13.3. Latin America Organoids Market Value Forecast, by Application, 2018–2030
13.3.1. Developmental Biology
13.3.2. Disease Pathology of Infectious Disease
13.3.3. Regenerative Medicine
13.3.4. Drug Toxicity & Efficacy Testing
13.3.5. Drug Discovery & Personalized Medicine
13.3.6. Others
13.4. Latin America Organoids Market Value Forecast, by Source, 2018–2030
13.4.1. Pluripotent Stem Cells (hIPSCs)
13.4.2. Organ-speci?c Adult Stem Cells (ASCs)
13.5. Latin America Organoids Market Value Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Organoids Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By Source
13.6.4. By Country/Sub-region
14. Middle East & Africa Organoids Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Organoids Market Value Forecast, by Type,2018–2030
14.2.1. Stomach
14.2.2. Intestine
14.2.3. Liver
14.2.4. Pancreas
14.2.5. Lung
14.2.6. Brain
14.2.7. Kidney
14.2.8. Others
14.3. Middle East & Africa Organoids Market Value Forecast, by Application, 2018–2030
14.3.1. Developmental Biology
14.3.2. Disease Pathology of Infectious Disease
14.3.3. Regenerative Medicine
14.3.4. Drug Toxicity & Efficacy Testing
14.3.5. Drug Discovery & Personalized Medicine
14.3.6. Others
14.4. Middle East & Africa Organoids Market Value Forecast, by Source, 2018–2030
14.4.1. Pluripotent Stem Cells (hIPSCs)
14.4.2. Organ-speci?c Adult Stem Cells (ASCs)
14.5. Middle East & Africa Organoids Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Organoids Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By Source
14.6.4. By Country/Sub-region
15. Competitive Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1.STEMCELL Technologies, Inc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2.Cellesce Ltd
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Strategic Overview
15.2.2.4. SWOT Analysis
15.2.3. Hubrecht Organoid Technology
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Strategic Overview
15.2.3.4. SWOT Analysis
15.2.4.Definigen
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Strategic Overview
15.2.4.4. SWOT Analysis
15.2.5.3Dnamics, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6.Organoid Therapeutics
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Strategic Overview
15.2.6.4. SWOT Analysis
15.2.7. PeproTech, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Strategic Overview
15.2.7.4. SWOT Analysis
15.2.8. Thermo Fisher Scientific
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Financial Overview
15.2.8.3. Product Portfolio
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9.Corning Incorporated (Life Sciences)
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Financial Overview
15.2.9.3. Product Portfolio
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Merck KGgA
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Financial Overview
15.2.10.3. Product Portfolio
15.2.10.4. Strategic Overview
15.2.10.5. SWOT Analysis
List of Tables
Table 01: Global Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 02: Global Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 03: Global Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 04: Global Organoids Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 05: North America Organoids Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 06: North America Organoids Market Value Forecast, by Type, 2018–2030
Table 07: North America Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 08: North America Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 09: Europe Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 10: Europe Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 11: Europe Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 12: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 13: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 14: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 15: Latin America Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 16: Latin America Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 17: Latin America Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 18: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 19: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 20: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
List of Figures
Figure 01: Global Organoids Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Organoids Market Value Share, by Type, 2019
Figure 03:Global Organoids Market Value Share, by Application, 2019
Figure 04: Global Organoids Market Value Share, by Source, 2019
Figure 05: Global Organoids Market Value Share Analysis, by Type, 2019 and 2030
Figure 06: Global Organoids Market Value (US$ Mn), by Stomach, 2018–2030
Figure 07: Global Organoids Market Value (US$ Mn), by Intestine, 2018–2030
Figure 08: Global Organoids Market Value (US$ Mn), by Liver, 2018–2030
Figure 09: Global Organoids Market Value (US$ Mn), by Pancreas, 2018–2030
Figure 10: Global Organoids Market Value (US$ Mn), by Lung, 2018–2030
Figure 11: Global Organoids Market Value (US$ Mn), by Brain, 2018–2030
Figure 12: Global Organoids Market Value (US$ Mn), by Kidney, 2018–2030
Figure 13: Global Organoids Market Value (US$ Mn), by Others , 2018–2030
Figure 14: Global Organoids Market Attractiveness Analysis, by Type, 2020–2030
Figure 15: Global Organoids Market Value Share Analysis, by Application, 2019 and 2030
Figure 16: Global Organoids Market Value (US$ Mn), by Developmental Biology , 2018–2030
Figure 17: Global Organoids Market Value (US$ Mn), by Disease Pathology of Infectious Disease, 2018–2030
Figure 18: Global Organoids Market Value (US$ Mn), by Regenerative Medicine, 2018–2030
Figure 19: Global Organoids Market Value (US$ Mn), by Drug Toxicity & Efficacy Testing, 2018–2030
Figure 20: Global Organoids Market Value (US$ Mn), by Drug Discovery & Personalized Medicine, 2018–2030
Figure 21: Global Organoids Market Value (US$ Mn), by Others, 2018–2030
Figure 22: Global Organoids Market Attractiveness Analysis, by Application, 2020–2030
Figure 23: Global Organoids Market Value Share Analysis, by Source, 2019 and 2030
Figure 24: Global Organoids Market Value (US$ Mn), by Pluripotent Stem Cells (hIPSCs), 2018–2030
Figure 25: Global Organoids Market Value (US$ Mn), by Organ-speci?c Adult Stem Cells (ASCs),2018–2030
Figure 26: Global Organoids Market Attractiveness Analysis, by Source, 2020–2030
Figure 27 : Global Organoids Market Value Share Analysis, by Region, 2019 and 2030
Figure 28 : Global Organoids Market Attractiveness Analysis, by Region, 2020–2030
Figure 29: North America Organoids Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 30: North America Organoids Market Value Share (%), by Country, 2019 and 2030
Figure 31: North America Organoids Market Attractiveness Analysis, by Country, 2020–2030
Figure 32: North America Organoids Market Value Share (%), by Type, 2019 and 2030
Figure 33: North America Organoids Market Attractiveness Analysis, by Type, 2020–2030
Figure 34: North America Organoids Market Value Share (%), by Application, 2019 and 2030
Figure 35: North America Organoids Market Attractiveness Analysis, by Application, 2020–2030
Figure 36: North America Organoids Market Value Share (%), by Source, 2019 and 2030
Figure 37: North America Organoids Market Attractiveness Analysis, by Source, 2020–2030
Figure 38: Europe Organoids Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 39: Europe Organoids Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 40: Europe Organoids Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 41: Europe Organoids Market Value Share (%), by Type, 2019 and 2030
Figure 42: Europe Organoids Market Attractiveness Analysis, by Type, 2020–2030
Figure 43: Europe Organoids Market Value Share (%), by Application, 2019 and 2030
Figure 44: Europe Organoids Market Attractiveness Analysis, by Application, 2020–2030
Figure 45: Europe Organoids Market Value Share (%), by Source, 2019 and 2030
Figure 46: Europe Organoids Market Attractiveness Analysis, by Source, 2020–2030
Figure 47: Asia Pacific Organoids Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 48: Asia Pacific Organoids Market Value Share (%), by Country/Region, 2019 and 2030
Figure 49: Asia Pacific Organoids Market Attractiveness Analysis, by Country/Region, 2020–2030
Figure 50: Asia Pacific Organoids Market Value Share (%), by Type, 2019 and 2030
Figure 51: Asia Pacific Organoids Market Attractiveness Analysis, by Type, 2020–2030
Figure 52: Asia Pacific Organoids Market Value Share (%), by Application, 2019 and 2030
Figure 53: Asia Pacific Organoids Market Attractiveness Analysis, by Application, 2020–2030
Figure 54: Asia Pacific Organoids Market Value Share (%), by Source, 2019 and 2030
Figure 55: Asia Pacific Organoids Market Attractiveness Analysis, by Source, 2020–2030
Figure 56: Latin America Organoids Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 57: Latin America Organoids Market Value Share (%), by Country/Region, 2019 and 2030
Figure 58: Latin America Organoids Market Attractiveness Analysis, by Country/Region, 2020–2030
Figure 59: Latin America Organoids Market Value Share (%), by Type, 2019 and 2030
Figure 60: Latin America Organoids Market Attractiveness Analysis, by Type, 2020–2030
Figure 61: Latin America Organoids Market Value Share (%), by Application, 2019 and 2030
Figure 62: Latin America Organoids Market Attractiveness Analysis, by Application, 2020–2030
Figure 63: Latin America Organoids Market Value Share (%), by Source, 2019 and 2030
Figure 64: Latin America Organoids Market Attractiveness Analysis, by Source, 2020–2030
Figure 65: Middle East & Africa Organoids Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 66: Middle East & Africa Organoids Market Value Share (%), by Country/Region, 2019 and 2030
Figure 67: Middle East & Africa Organoids Market Attractiveness Analysis, by Country/Region, 2020–2030
Figure 68: Middle East & Africa Organoids Market Value Share (%), by Type, 2019 and 2030
Figure 69: Middle East & Africa Organoids Market Attractiveness Analysis, by Type, 2020–2030
Figure 70: Middle East & Africa Organoids Market Value Share (%), by Application, 2019 and 2030
Figure 71: Middle East & Africa Organoids Market Attractiveness Analysis, by Application, 2020–2030
Figure 72: Middle East & Africa Organoids Market Value Share (%), by Source, 2019 and 2030
Figure 73: Middle East & Africa Organoids Market Attractiveness Analysis, by Source, 2020–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Organoids Market
